Sharps Technology, Inc.
General ticker "STSS" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $92.0M (TTM average)
Sharps Technology, Inc. does not follow the US Stock Market performance with the rate: -21.0%.
Estimated limits based on current volatility of 6.0%: low 1.17$, high 1.32$
Factors to consider:
- Total employees count: 57 (-1.7%) as of 2023
- Top business risk factors: Early stage company with historical losses, Unanticipated expenses and technical difficulties, Dependence on inventory and manufacturing scale, Market competition, Product recalls
- Current price 53.2% below estimated low
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.57$, 9.29$]
- 2026-12-31 to 2027-12-31 estimated range: [1.59$, 6.09$]
Financial Metrics affecting the STSS estimates:
- Positive: with PPE of 0.1 at the end of fiscal year the price was very low
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Positive: Inventory ratio change, % of -24.03 <= -0.75
- Positive: Return on assets ratio (scaled to [-100,100]) of 50.12 > 6.06
- Positive: -9.55 < Industry operating profit margin (median), % of -3.62
- Positive: Interest expense per share per price, % of 0.78 <= 3.31
- Positive: Shareholder equity ratio, % of 98.26 > 64.29
- Positive: -0.03 < Industry operating cash flow per share per price (median), % of 1.51
Short-term STSS quotes
Long-term STSS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.20MM |
| Operating Expenses | $10.13MM | $7.86MM | $13.50MM |
| Operating Income | $-10.13MM | $-7.86MM | $-13.29MM |
| Non-Operating Income | $0.26MM | $-1.47MM | $-257.04MM |
| Interest Expense | $0.00MM | $0.00MM | $0.42MM |
| R&D Expense | $1.61MM | $2.47MM | $0.20MM |
| Income(Loss) | $-9.87MM | $-9.33MM | $-270.34MM |
| Taxes | $-0.03MM | $-0.03MM | $-0.00MM |
| Net Income(Loss)* | $-9.84MM | $-9.30MM | $-282.50MM |
| Stockholders Equity | $7.93MM | $2.00MM | $264.38MM |
| Inventory | $1.71MM | $1.87MM | $0.65MM |
| Assets | $11.79MM | $7.31MM | $269.08MM |
| Operating Cash Flow | $-8.51MM | $-6.93MM | $-16.72MM |
| Capital expenditure | $0.70MM | $0.14MM | $0.00MM |
| Investing Cash Flow | $-0.70MM | $-1.16MM | $-189.16MM |
| Financing Cash Flow | $8.03MM | $5.91MM | $215.51MM |
| Earnings Per Share** | $-4,985.63 | $-2,220.25 | $-11.16 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.